JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 23, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/13/9640    most recent
M008201200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prévôt, D.
Right arrow Articles by Corbo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prévôt, D.
Right arrow Articles by Corbo, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 2, 2001
J. Biol. Chem, 10.1074/jbc.M008201200
Submitted on September 7, 2000
Revised on November 26, 2000
Accepted on January 2, 2001

Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway

Déborah Prévôt, Anne-Pierre Morel, Thibault Voeltzel, Marie-Claude Rostan, Ruth Rimokh, Jean-Pierre Magaud, and Laura Corbo

INSERM U453, Centre Leon Berard, Lyon 69373 Cedex 08

Corresponding Author: corbo{at}lyon.fnclcc.fr

We have previously reported the interaction of BTG1 and BTG2 with the mouse protein CAF1 (CCR4 associated factor 1) and suggested that these proteins may participate, through their association with CAF1, in transcription regulation. Here we describe the in vitro and in vivo association of these proteins with hPOP2, the human paralog of hCAF1. The physical and functional relationships between the BTG proteins and their partners hCAF1 and hPOP2 were investigated in order to find out how these interactions affect cellular processes, and in particular transcription regulation. We described their interaction regions and examined their expression in various human tissues. We also show functional data indicating their involvement in Estrogen Receptoralpha (ERalpha )-mediated transcription regulation. We found that BTG1 and BTG2, probably through their interaction with CAF1 or POP2 via a CCR4-like complex, can play both positive or negative roles in regulating the ERalpha function. In addition, our results indicate that two LxxLL motifs, referred to as nuclear receptor boxes, present in both BTG1 and BTG2, are involved in the regulation of ERalpha -mediated activation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GeneticsHome page
A. Manukyan, J. Zhang, U. Thippeswamy, J. Yang, N. Zavala, M. P. Mudannayake, M. Asmussen, C. Schneider, and B. L. Schneider
Ccr4 Alters Cell Size in Yeast by Modulating the Timing of CLN1 and CLN2 Expression
Genetics, May 1, 2008; 179(1): 345 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Garapaty, M. A. Mahajan, and H. H. Samuels
Components of the CCR4-NOT Complex Function as Nuclear Hormone Receptor Coactivators via Association with the NRC-interacting Factor NIF-1
J. Biol. Chem., March 14, 2008; 283(11): 6806 - 6816.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Robin-Lespinasse, S. Sentis, C. Kolytcheff, M.-C. Rostan, L. Corbo, and M. Le Romancer
hCAF1, a new regulator of PRMT1-dependent arginine methylation
J. Cell Sci., February 15, 2007; 120(4): 638 - 647.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. Donato, J. H. Suh, and N. Noy
Suppression of Mammary Carcinoma Cell Growth by Retinoic Acid: the Cell Cycle Control Gene Btg2 Is a Direct Target for Retinoic Acid Receptor Signaling
Cancer Res., January 15, 2007; 67(2): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kawakubo, E. Brachtel, T. Hayashida, G. Yeo, J. Kish, A. Muzikansky, P. D. Walden, and S. Maheswaran
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Cancer Res., July 15, 2006; 66(14): 7075 - 7082.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Passeri, A. Marcucci, G. Rizzo, M. Billi, M. Panigada, L. Leonardi, F. Tirone, and F. Grignani
Btg2 enhances retinoic Acid-induced differentiation by modulating histone h4 methylation and acetylation.
Mol. Cell. Biol., July 1, 2006; 26(13): 5023 - 5032.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Sentis, M. Le Romancer, C. Bianchin, M.-C. Rostan, and L. Corbo
Sumoylation of the Estrogen Receptor {alpha} Hinge Region Regulates Its Transcriptional Activity
Mol. Endocrinol., November 1, 2005; 19(11): 2671 - 2684.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
C. BIANCHIN, F. MAUXION, S. SENTIS, B. SERAPHIN, and L. CORBO
Conservation of the deadenylase activity of proteins of the Caf1 family in human
RNA, April 1, 2005; 11(4): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
K. Okochi, T. Suzuki, J.-i. Inoue, S. Matsuda, and T. Yamamoto
Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control
Genes Cells, February 1, 2005; 10(2): 151 - 163.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Park, Y. J. Lee, H.-J. Lee, T. Seki, K.-H. Hong, J. Park, H. Beppu, I. K. Lim, J.-W. Yoon, E. Li, et al.
B-Cell Translocation Gene 2 (Btg2) Regulates Vertebral Patterning by Modulating Bone Morphogenetic Protein/Smad Signaling
Mol. Cell. Biol., December 1, 2004; 24(23): 10256 - 10262.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hamatani, T. Daikoku, H. Wang, H. Matsumoto, M. G. Carter, M. S. H. Ko, and S. K. Dey
Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation
PNAS, July 13, 2004; 101(28): 10326 - 10331.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Berthet, A.-M. Morera, M.-J. Asensio, M.-A. Chauvin, A.-P. Morel, F. Dijoud, J.-P. Magaud, P. Durand, and J.-P. Rouault
CCR4-Associated Factor CAF1 Is an Essential Factor for Spermatogenesis
Mol. Cell. Biol., July 1, 2004; 24(13): 5808 - 5820.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
W. J. Bakker, M. Blazquez-Domingo, A. Kolbus, J. Besooyen, P. Steinlein, H. Beug, P. J. Coffer, B. Lowenberg, M. von Lindern, and T. B. van Dijk
FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1
J. Cell Biol., January 19, 2004; 164(2): 175 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Lee, S. Cha, M.-S. Lee, G. J. Cho, W. S. Choi, and K. Suk
Role of Antiproliferative B Cell Translocation Gene-1 as an Apoptotic Sensitizer in Activation-Induced Cell Death of Brain Microglia
J. Immunol., December 1, 2003; 171(11): 5802 - 5811.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Sotiriou, S.-Y. Neo, L. M. McShane, E. L. Korn, P. M. Long, A. Jazaeri, P. Martiat, S. B. Fox, A. L. Harris, and E. T. Liu
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
PNAS, September 2, 2003; 100(18): 10393 - 10398.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A.-P. Morel, S. Sentis, C. Bianchin, M. Le Romancer, L. Jonard, M.-C. Rostan, R. Rimokh, and L. Corbo
BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms
J. Cell Sci., July 15, 2003; 116(14): 2929 - 2936.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. Yoshida, T. Nakamura, M. Komoda, H. Satoh, T. Suzuki, J. K. Tsuzuku, T. Miyasaka, E. H. Yoshida, H. Umemori, R. K. Kunisaki, et al.
Mice lacking a transcriptional corepressor Tob are predisposed to cancer
Genes & Dev., May 15, 2003; 17(10): 1201 - 1206.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Gomes, T. T. Sharma, S. Edassery, N. Fulton, B. G. Mar, and C. A. Westbrook
Novel transcription factors in human CD34 antigen-positive hematopoietic cells
Blood, June 17, 2002; 100(1): 107 - 119.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. J. van der Meijden, D. S. Lapointe, M. X. Luong, D. Peric-Hupkes, B. Cho, J. L. Stein, A. J. van Wijnen, and G. S. Stein
Gene Profiling of Cell Cycle Progression through S-Phase Reveals Sequential Expression of Genes Required for DNA Replication and Nucleosome Assembly
Cancer Res., June 1, 2002; 62(11): 3233 - 3243.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T. Suzuki, J. K-Tsuzuku, R. Ajima, T. Nakamura, Y. Yoshida, and T. Yamamoto
Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation
Genes & Dev., June 1, 2002; 16(11): 1356 - 1370.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.